Last reviewed · How we verify
docetaxel, nedaplatin, and fluorouracil
docetaxel, nedaplatin, and fluorouracil is a Small molecule drug developed by Sun Yat-sen University. It is currently in Phase 3 development. Also known as: TNF induction chemotherapy.
At a glance
| Generic name | docetaxel, nedaplatin, and fluorouracil |
|---|---|
| Also known as | TNF induction chemotherapy |
| Sponsor | Sun Yat-sen University |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC (PHASE3)
- Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma (PHASE3)
- Nedaplatin in Treatment for Nasopharyngeal Carcinoma (PHASE2)
- Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma
- Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
- CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy (PHASE3)
- Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- docetaxel, nedaplatin, and fluorouracil CI brief — competitive landscape report
- docetaxel, nedaplatin, and fluorouracil updates RSS · CI watch RSS
- Sun Yat-sen University portfolio CI
Frequently asked questions about docetaxel, nedaplatin, and fluorouracil
What is docetaxel, nedaplatin, and fluorouracil?
docetaxel, nedaplatin, and fluorouracil is a Small molecule drug developed by Sun Yat-sen University.
Who makes docetaxel, nedaplatin, and fluorouracil?
docetaxel, nedaplatin, and fluorouracil is developed by Sun Yat-sen University (see full Sun Yat-sen University pipeline at /company/sun-yat-sen-university).
Is docetaxel, nedaplatin, and fluorouracil also known as anything else?
docetaxel, nedaplatin, and fluorouracil is also known as TNF induction chemotherapy.
What development phase is docetaxel, nedaplatin, and fluorouracil in?
docetaxel, nedaplatin, and fluorouracil is in Phase 3.
Related
- Manufacturer: Sun Yat-sen University — full pipeline
- Also known as: TNF induction chemotherapy
- Compare: docetaxel, nedaplatin, and fluorouracil vs similar drugs
- Pricing: docetaxel, nedaplatin, and fluorouracil cost, discount & access